Surveying the evidence landscape for UK-focused spatial climate risk assessment

Complete

Value

£100,000

Classifications

  • Research and development services and related consultancy services

Tags

  • tenderAmendment

Submission Deadline

1 year ago

Published

1 year ago

Description

1	Background

The Climate Change Committee  
The Climate Change Committee (CCC) was set up as part of the Climate Change Act. The CCC is an independent body that advises both on reducing emissions in the UK and adapting to the climate changes in the UK.   
 
The CCC's full range of past reports are available here:   
http://www.theccc.org.uk/reports/.  

The UK Climate Change Risk Assessment  
        
Under the Climate Change Act 2008 (section 57), an assessment of the risks facing the UK from the current and predicted impact of climate change is required every 5 years. The CCC is responsible for providing independent advice to the UK Government to inform that assessment.  
 
The Committee has recently provided its advice to the UK Government on the risks and opportunities facing the UK from current and future climate change as part of the third Climate Change Risk Assessment (CCRA3) - this was summarised in its Independent Assessment of UK Climate Risk which was published in summer 2021.     
 
The fourth UK Climate Change Risk Assessment (CCRA4) is due for completion by June 2026. CCRA4 will assess climate change risks to the UK using a more spatially defined approach than previous CCRAs, giving an assessment of the spatial distribution of climate risks across the UK and a more localised view of adaptation needs.  
 
In order to assess climate risks at a spatial scale in CCRA4, the CCC are seeking to identify existing spatial modelling tools, initiatives and datasets that can be used to assess the spatial distribution of climate risks across the economy and the natural environment.  

2	Aims and Objectives

The aim of this project is to review the current landscape of spatial modelling of climate risks to the UK. This project will seek to identify existing models capable of UK-wide spatially explicit climate risk assessment within different sectors and ongoing modelling initiatives producing spatially explicit outputs relevant to UK climate risk assessment.  
 
The purpose of this exercise is to understand what tools and existing simulations could be used to inform spatial risk assessment in CCRA4.  
 
**** See specification for more details ****

Additional information: Please note the change in closing date from 5pm on Wednesday 25th January 2023 to 11:59pm 29th January 2023

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete